000 | 01390 a2200349 4500 | ||
---|---|---|---|
005 | 20250514195156.0 | ||
264 | 0 | _c20041108 | |
008 | 200411s 0 0 eng d | ||
022 | _a0160-9289 | ||
024 | 7 |
_a10.1002/clc.4960270703 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aManoharan, Ganesh | |
245 | 0 | 0 |
_aConsiderations in combination therapy: fibrinolytics plus glycoprotein IIb/IIIa receptor inhibitors in acute myocardial infarction. _h[electronic resource] |
260 |
_bClinical cardiology _cJul 2004 |
||
300 |
_a381-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
650 | 0 | 4 |
_aCoronary Stenosis _xtherapy |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMyocardial Infarction _xtherapy |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
650 | 0 | 4 | _aThrombolytic Therapy |
650 | 0 | 4 |
_aVascular Patency _xdrug effects |
700 | 1 | _aAdgey, A A Jennifer | |
773 | 0 |
_tClinical cardiology _gvol. 27 _gno. 7 _gp. 381-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/clc.4960270703 _zAvailable from publisher's website |
999 |
_c14997856 _d14997856 |